Longwood Fund — 2018 Investments
1 investments dated 2018 · listed companies and verified rows first · show all
Axial BiotherapeuticsNov 2018SEC filingmedium confidence
BiotechBoston, US
SARKIS K. MAZMANIAN(Director)DAVID H. DONABEDIAN(CHIEF EXECUTIVE OFFICER OF THE ISSUER)Ronald C. Renaud Jr.(Director)Henry Wolf(Director)
BoardJAMES C. BLAIR(Director)MICHELLE DIPP(Director)
Board seatRichard P. Aldrich· per SEC Form D · $28M raise · filed Nov 2018
Co-investorsDomain Partners
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.